Veeva Systems (NYSE:VEEV) Updates Q3 2025 Earnings Guidance

Veeva Systems (NYSE:VEEV) issued an update on its third quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 1.570-1.580 for the period, compared to the consensus EPS estimate of 1.550. The company issued revenue guidance of $682.0 million-$685.0 million, compared to the consensus revenue estimate of $685.3 million. Veeva Systems also updated its FY 2025 guidance to 6.220-6.220 EPS.

Veeva Systems Trading Up 8.6 %

Shares of Veeva Systems stock traded up $17.14 during trading hours on Thursday, reaching $216.49. The stock had a trading volume of 641,430 shares, compared to its average volume of 953,706. Veeva Systems has a twelve month low of $162.72 and a twelve month high of $236.90. The firm has a market capitalization of $35.00 billion, a PE ratio of 62.95, a PEG ratio of 1.95 and a beta of 0.80. The stock’s 50 day moving average is $187.82 and its 200 day moving average is $202.03.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, August 28th. The technology company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.03. Veeva Systems had a return on equity of 12.74% and a net margin of 22.34%. The company had revenue of $676.18 million for the quarter, compared to analysts’ expectations of $667.21 million. As a group, sell-side analysts predict that Veeva Systems will post 4.19 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on VEEV. Barclays increased their target price on shares of Veeva Systems from $220.00 to $240.00 and gave the company an overweight rating in a research report on Thursday. Citigroup raised their target price on shares of Veeva Systems from $256.00 to $273.00 and gave the stock a buy rating in a research note on Tuesday. Royal Bank of Canada reissued an outperform rating and set a $250.00 price objective on shares of Veeva Systems in a research note on Thursday. Morgan Stanley dropped their price objective on shares of Veeva Systems from $210.00 to $173.00 and set an underweight rating for the company in a report on Friday, May 31st. Finally, Robert W. Baird lifted their target price on shares of Veeva Systems from $245.00 to $251.00 and gave the stock an outperform rating in a research note on Thursday. One analyst has rated the stock with a sell rating, six have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and an average price target of $231.86.

Insiders Place Their Bets

In other news, SVP Jonathan Faddis sold 2,353 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $200.00, for a total transaction of $470,600.00. Following the sale, the senior vice president now owns 9,035 shares of the company’s stock, valued at approximately $1,807,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP Jonathan Faddis sold 2,353 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $200.00, for a total value of $470,600.00. Following the transaction, the senior vice president now owns 9,035 shares of the company’s stock, valued at $1,807,000. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Timothy S. Cabral sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $184.33, for a total value of $2,764,950.00. Following the completion of the sale, the chief financial officer now directly owns 8,391 shares of the company’s stock, valued at $1,546,713.03. The disclosure for this sale can be found here. 10.50% of the stock is currently owned by company insiders.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.